Ventricular Tachycardia Detection Using RR Intervals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices (IMDs) for detecting ventricular tachycardia (VT) face challenges in accurately differentiating monomorphic VT from other tachycardias due to limited processing capacity, often relying on complex algorithms that are not feasible for miniaturized pacemakers, leading to potential misdiagnosis and inappropriate therapy delivery.
Innovation Solution
An intracardiac pacemaker system that utilizes RR interval-based detection criteria, applying non-sinus rhythm, supraventricular tachycardia rejection, and tachycardia detection interval criteria to specifically identify monomorphic VT, allowing for anti-tachycardia pacing (ATP) delivery before shock therapy, thereby minimizing patient discomfort and conserving device battery life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex algorithms are used for VT detection, then detection accuracy is improved, but device complexity and processing requirements increase beyond what miniaturized pacemakers can handle
Solution Approach 1:
The patent extracts only the essential RR interval parameter from the complete cardiac signal for VT detection, eliminating the need for complex waveform morphology analysis. This extraction approach maintains detection accuracy for monomorphic VT while significantly reducing computational requirements to fit within miniaturized pacemaker constraints.
Solution Approach 2:
The patent changes the detection parameter from complex waveform morphology to simple RR interval measurements. By monitoring changes in RR intervals over time and comparing them against programmed thresholds, the system achieves effective VT detection with minimal processing power, resolving the contradiction between accuracy and device complexity.
2Reliability
If shock therapy is delivered for all detected tachycardias, then life-threatening conditions are treated, but patient discomfort increases and battery life decreases
Solution Approach 1:
The patent applies different therapy qualities to different detected conditions: monomorphic VT receives gentle ATP therapy while other tachycardias receive shock therapy. This localized differentiation allows effective treatment of the most common tachycardia type with minimal discomfort, while maintaining reliability for life-threatening conditions.
Solution Approach 2:
The patent employs a hierarchical therapy approach where a less invasive, lower-energy ATP therapy is attempted first for monomorphic VT. This 'cheaper' initial therapy conserves battery life and reduces patient discomfort, with shock therapy reserved as a backup for non-responsive cases or more severe arrhythmias.
3Device complexity
If simple detection criteria are used, then device complexity is reduced, but ability to differentiate monomorphic VT from other tachycardias deteriorates
Solution Approach 1:
The patent makes the simple RR interval measurement serve multiple differentiation functions: detecting monomorphic VT, rejecting supraventricular tachycardia, and identifying polymorphic VT through programmed criteria. This universal approach allows one simple parameter to perform what previously required multiple complex measurements.
Solution Approach 2:
The patent introduces dynamic monitoring of RR interval changes over time with programmed thresholds. By continuously comparing current RR intervals against historical values and applying rate-based criteria, the system achieves accurate tachycardia differentiation using only simple interval measurements, maintaining both simplicity and precision.
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
An implantable medical device system includes a pacemaker and an extravascular implantable cardioverter defibrillator (ICD). The pacemaker is configured to acquire a cardiac electrical signal, determine RR intervals from the cardiac electrical signal, apply ventricular tachycardia detection criteria solely to the RR intervals, detect ventricular tachycardia (VT) when the detection criteria are met; and deliver anti-tachycardia pacing in response to detecting the VT before the extravascular ICD delivers a shock therapy.